U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07896876) titled 'Selenium, Sarcopenia, and Frailty in Hemodialysis' on Oct. 20.
Brief Summary: Chronic kidney disease (CKD) is a significant public health issue with an increasing prevalence worldwide. In patients undergoing hemodialysis (HD) in particular, various factors-such as chronic inflammation, oxidative stress, nutritional disorders, and micronutrient deficiencies-can negatively affect muscle health and physical function. Selenium, an essential trace element with potent antioxidant properties, has been shown to be present at low levels in these patients and may be associated with muscle strength. Sarcopenia and frailty are critical clinical...